OVCAR-3 was established in 1982 by T.C. Hamilton, et al. from the malignant ascites of a patient with progressive adenocarcinoma of the ovary. The RFP Stable Cell Line-OVCAR3 constitutively expresses RFP.
This cryovial contains at least 1.0 × 10^6 cells as determined by morphology, trypan-blue dye exclusion, and viable cell count. The cells are tested free of microbial contamination.
Inquiry for instruction of culturing